在败血症诱导的免疫抑制中,Tim-3途径失调和向
Jialiu Luo1, Cong Zhang1, Deng Chen1
1Department of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Trauma Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
European journal of medical research
|December 19, 2024
概括
败血症导致免疫抑制,增加死亡率. 本综述探讨了T细胞免疫球蛋白和粘素域3 (Tim-3) 信号在败血症诱导的免疫抑制和Tim-3阻塞治疗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
- 翻译医学是一种翻译医学.
背景情况:
- 败血症是一种危及生命的疾病,全球死亡率高.
- 败血症包括炎症和免疫抑制,免疫抑制增加了二次感染风险.
- 败血症诱导的免疫抑制的关键特征包括T细胞耗尽和改变的免疫检查点分子表达.
研究的目的:
- 审查T细胞免疫球蛋白和粘素域3 (Tim-3) 信号传递在败血症诱导的免疫抑制中的作用.
- 评估治疗潜力和围绕毒症Tim-3封锁的争议.
主要方法:
- 对 Tim-3 信号在败血症中的研究进行文献综述.
- 关于Tim-3连接体及其在败血症期间免疫细胞中的功能的证据分析.
- 在癌症免疫疗法和败血症模型中对抗Tim-3抗体疗效的数据的检查.
主要成果:
- 蒂姆-3是一种免疫检查点分子,在各种免疫细胞上表达.
- 蒂姆-3及其连接物在败血症期间与免疫细胞功能障碍有关.
- 尽管在癌症免疫治疗中取得了成功,但Tim-3阻塞在败血症模型中的治疗疗效仍在争论中.
结论:
- 了解Tim-3信号对于解决败血症引起的免疫抑制至关重要.
- 需要进一步的研究来澄清Tim-3阻塞在败血症治疗中的确切作用和治疗潜力.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


